Mission Pharmacal Drug Patent Portfolio

Mission Pharmacal owns 1 orange book drug protected by 1 US patent Given below is the list of Mission Pharmacal's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11458104 Enteric coated tiopronin tablet 14 Nov, 2038
Active


Given below is the list of recent legal activities going on the following drug patents of Mission Pharmacal.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation 04 Oct, 2022 US11458104
Recordation of Patent Grant Mailed 04 Oct, 2022 US11458104
Application ready for PDX access by participating foreign offices 04 Oct, 2022 US11458104
Email Notification 15 Sep, 2022 US11458104
Issue Notification Mailed 14 Sep, 2022 US11458104
Dispatch to FDC 12 Sep, 2022 US11458104
Application Is Considered Ready for Issue 12 Sep, 2022 US11458104
Email Notification 05 Aug, 2022 US11458104
Mailing Corrected Notice of Allowability 05 Aug, 2022 US11458104
Corrected Notice of Allowability 01 Aug, 2022 US11458104
Issue Fee Payment Received 26 Jul, 2022 US11458104
Issue Fee Payment Verified 26 Jul, 2022 US11458104
Pubs Case Remand to TC 19 Jul, 2022 US11458104
Electronic Review 13 Jul, 2022 US11458104
Email Notification 13 Jul, 2022 US11458104


Mission Pharmacal's Drug Patent Litigations

Mission Pharmacal's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Oct 25, 2021, against patent number US11458104. The petitioner , challenged the validity of this patent, with Mission Pharmacal Company as the respondent. Click below to track the latest information on how companies are challenging Mission Pharmacal's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US11458104 October, 2021 Decision
(15 Mar, 2022)
Mission Pharmacal Company


Mission Pharmacal's Family Patents


Family Patents



Mission Pharmacal Drug List

Given below is the complete list of Mission Pharmacal's drugs and the patents protecting them.


1. Thiola Ec

Thiola Ec is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11458104 Enteric coated tiopronin tablet 14 Nov, 2038
(14 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Thiola Ec's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List